alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXPERT CONSENT


I, Byard Harold MacLean, do hereby consent to (i) the filing of the written disclosure regarding the technical report entitled “Prairie Creek Property Northwest Territories, Canada Technical Report for Canadian Zinc Corporation” with an effective date of June 15, 2012 and other capital cost estimate information pertaining to the Prairie Creek Property in the Management Discussion & Analysis for the year ended December 31, 2012 of Canadian Zinc Corporation (the “Company”), and (ii) the use of my name in the MD&A and Annual Report on Form 40-F of the Company for the year ended December 31, 2012 and any amendments thereto incorporating by reference the Company’s MD&A and the Annual Report on Form 40-F.


Dated this 19th day of March, 2013.


/s/ Byard Howard MacLean
 Name: Byard Howard MacLean


1
'3,99/4 J. aka 

Douglas Cherry 

J. 

In an attempt to overcome the procedural bars, appellant 

argued that Martinez v. Ryan, 566 U.S. , 132 S. Ct. 1309 (2012), 

provides a gateway through the procedural bars in cases like his where 

the petitioner has been deprived of the benefit of counsel when pursuing 

claims of ineffective assistance of trial counsel. Martinez held that "a 

procedural default will not bar a federal habeas court from hearing a 

substantial claim of ineffective assistance [of counsel] at trial if, in the 

initial-review collateral proceeding, there was no counsel or counsel in 

that proceeding was ineffective." 566 U.S. at , 132 S. Ct. at 1320 

(emphasis added). We have recently determined that Martinez does not 

apply to habeas petitions filed in state court. Brown v. McDaniel, 130 

Nev. P.3d (Adv. Op. No. 60, at 15-16, August 7, 2014). 

Accordingly, we conclude that appellant failed to overcome the procedural 

bars to his petition, and we 

ORDER the judgment of the district court AFFIRMED. 3 

' J. 

Hardesty 

3We have reviewed all documents that appellant has submitted in 

proper person to the clerk of this court in this matter, and we conclude 

that no relief based upon those submissions is warranted. To the extent 

that appellant has attempted to present claims or facts in those 

submissions which were not previously presented in the proceedings 

below, we have declined to consider them in the first instance. 

SUPREME COURT 

OF 

NEVADA 2 

(0) 19474 e 
cc: Hon. Abbi Silver, District Judge 

Charles H. Porter 

Attorney General/Carson City 

Clark County District Attorney 

Eighth District Court Clerk 

SUPREME COURT 

OF 

NEVADA 3 

(0) 1947A e
##### Table of Contents



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C. 20549
 
 Form 8-K
 CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act
of 1934
 Date of Report (Date of earliest event reported): December 10, 2008
 SM&A
 (Exact name of registrant as specified in its charter)
 Delaware
    
    0-23585
    
    33-0080929(State or other jurisdiction 
of incorporation)
    
    (Commission
File Number)
    
    (IRS Employer
Identification No.)
 4695 MacArthur Court, 8th Floor, Newport Beach, California
    
    92660(Address of principal executive offices)
    
    (Zip Code)
 (949) 975-1550
 (Former name or former address, if changed since last report.)
 see
 o
    
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)o
    
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)o
    
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))o
    
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))




---



TABLE OF CONTENTS  Item 8.01 Other EventsItem 9.01 Financial Statements and ExhibitsSIGNATURESExhibit ListEX-99.1    Table of Contents  
 Item 8.01 Other Events
   
 Item 9.01 Financial Statements and Exhibits.
  2




---



##### Table of Contents



SIGNATURES
  December 10, 2008
    SM&ABy:
    /s/ James R. EckstaedtName:
    James R. EckstaedtTitle:
    Executive Vice President, Finance
and Chief Financial Officer 3




---



##### Table of Contents



Exhibit List
 Exhibit No.
    
    Description99.1
    
    Press Release dated December 10, 2008.
 4
exhibit10_2.htm


Exhibit 10.2


 


IMPERIUM ADVISERS, LLC


515 Madison Avenue


New York, NY 10022


 


January 11, 2012


 


Integrated BioPharma, Inc.


225 Long Avenue


Hillside, NJ 07205


 


Re:           Extension of Forbearance Agreement


 


Ladies and Gentlemen:


 


 


Reference is made to the Forbearance Agreement, dated as of October 4, 2011 (as amended, the “Forbearance Agreement”), by and between Integrated BioPharma, Inc. (the “Company”) and Imperium Advisers, LLC, in its capacity as collateral agent (in such “Collateral Agent”) for itself and the Investors referred to therein.  Capitalized terms used and not otherwise defined in this letter shall have the meanings ascribed to them in the Forbearance Agreement.


 


In consideration of the foregoing, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, it is hereby acknowledged, confirmed and agreed that all references in the Forbearance Agreement to “December 31, 2011” are hereby amended to mean “January 20, 2012”.


 


Furthermore, any interest payments which are due and payable to the Collateral Agent by the Company on or after the date of this letter through January 30, 2012 pursuant to terms of the 8% Senior Secured Notes of Integrated BioPharma, Inc. shall accrue and be due and payable on January 21, 2012.







Except as expressly modified pursuant hereto, no other changes or modifications to the Forbearance Agreement are intended or implied, and in all other respects, the Forbearance Agreement is hereby specifically ratified, restated and confirmed by the parties hereto as of the date hereof.







The effectiveness of this letter agreement shall be subject to the receipt by Collateral Agent of an original (or electronic copy) of this letter agreement duly executed and delivered by the Company.


 




 




	  	
Very truly yours,


	  	  
	  	
IMPERIUM ADVISERS, LLC,


	  	
As Collateral Agent on behalf of Investors


	  	  
	  	
By:  /s/ John Michaelson


	  	
Name:  John Michaelson


	  	
Title:  Manager












ACKNOWLEDGED, ACCEPTED AND AGREED:







INTEGRATED BIOPHARMA, INC.







By:  /s/ E. Gerald Kay


Name:  E. Gerald Kay


Title:  CEO
DISMISS; Opinion Filed February 7, 2013.

S

In The

Court of Appeals

Fifth District of Texas at Dallas

No. 05-12-00604-CV

IN THE INTEREST OF K.N.K. A MINOR CHILD

On Appeal from the 255th Judicial District Court

Dallas County, Texas

Trial Court Cause No. 06-17012-S

MEMORANDUM OPINION

Before Justices Moseley, Francis and Lang 

Opinion by Justice Moseley

By letter dated May 8, 2012, we notifed appellant the $175 filing fee in this case was due. 

We cautioned appellant that failure to file the fee within ten days would result in dismissal of the 

appeal. By letter dated July 25, 2012, we informed appellant that the Dallas County Clerk’s 

Office had notified us that the clerk’s record had not been filed in this case because appellant had 

not paid the clerk’s fee for the record. We directed appellant to, within ten days, file verification 

of payment or written documentation that appellant is entitled to proceed without payment of 

costs. We cautioned appellant that failure to file the required documentation might result in 

dismissal of the appeal for want of prosecution. To date, appellant has not paid the filing fee, 

provided verification that she has paid for the clerk’s record, provided written documentation 

that she is entitled to proceed without payment of costs, or otherwise corresponded with the 

Court regarding the status of this appeal.
2

Therefore, we dismiss this appeal. See TEX. R. APP. P. 42.3(b),(c).

Jim Moseley 

JIM MOSELEY

JUSTICE

120604F.P05
120604.op.docx 3

Court of Appeals

S

Fifth District of Texas at Dallas

JUDGMENT

EX PARTE IN THE INTEREST OF K.N.K. 

A MINOR CHILD

No. 05-12-00604-CV

On Appeal from the 255th Judicial District 

Court, Dallas County, Texas

Trial Court Cause No. 06-17012-S.

Opinion delivered by Justice Moseley. 

Justices Francis and Lang participating.

In accordance with this Court’s opinion of this date, this appeal is DISMISSED.

It is ORDERED that appellee Nitin Khanna recover his costs of this appeal from 

appellant Tara Khanna.

Judgment entered this 7th day of February, 2013.

/Jim Moseley/

JIM MOSELEY

JUSTICE
**EXHIBIT 32.1**

**CERTIFICATIONPURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT**

**August 11, 2006**

U. S. Securities and Exchange Commission450 Fifth Street, N. W.Washington, D.C. 20549

Ladies and Gentlemen:

The certification set forth below is being submitted tothe Securities and Exchange Commission solely for the purpose of complying withSection 1350 of Chapter 63 of Title 18 of the United States Code. Thiscertification is not to be deemed to be filed pursuant to the SecuritiesExchange Act of 1934 and does not constitute a part of the Quarterly Report onForm 10-Q (the “Report”) accompanying this letter and is not to beincorporated by reference into any filing, whether made before or after thedate hereof, regardless of any general incorporation language in such filing.

I, Robert E. Driscoll, the President and ChiefExecutive Officer of Mirant Americas Generation, LLC (the “Company”), certifythat, subject to the qualifications noted below, to the best of my knowledge:

1.                theReport fully complies with the requirements of Section 13(a) or 15(d) ofthe Securities Exchange Act of 1934; and

2.                the information contained in the Report fairlypresents, in all material respects, the financial condition and results ofoperations of Mirant Americas Generation, LLC.
| Name:  | /s/ ROBERT E.  DRISCOLL                 |   |
|--------|-----------------------------------------|--------|
|   | Robert E. Driscoll                      |   |
|   | *President and Chief Executive Officer* |   |

 

A signed original of this written statement requiredby Section 906 has been provided to Mirant Americas Generation, LLC andwill be retained by Mirant Americas Generation, LLC and furnished to theSecurities and Exchange Commission or its staff upon request.

----
<PAGE>   1
                                                                    EXHIBIT 23.2
 

                              ACCOUNTANTS' CONSENT
 

The Board of Directors
Candlewood Hotel Company, L.L.C.

We consent to the inclusion herein in the registration statement (No. 333-12021)
on Form S-1 of Candlewood Hotel Company, Inc. of our report dated August 23,
1996, relating to the consolidated balance sheets of Candlewood Hotel Company,
L.L.C. and subsidiaries as of December 31, 1995 and June 30, 1996 and the
related consolidated statements of operations, members' equity and cash flows
for the period from October 1, 1995 (date of inception) to December 31, 1995 and
for the six months ended June 30, 1996 and to the reference to our firm under
the heading "Experts" in the prospectus.

                                  KPMG Peat Marwick LLP

Wichita, Kansas
October 16, 1996
<PAGE>
                                                                   EXHIBIT 10.36

                     FIRST AMENDMENT TO AMENDED AND RESTATED
   NORTHWEST BIOTHERAPEUTICS, INC. LOAN AGREEMENT, SECURITY AGREEMENT AND 10%
                      CONVERTIBLE, SECURED PROMISSORY NOTE

        THIS FIRST AMENDMENT TO AMENDED AND RESTATED NORTHWEST
BIOTHERAPTUECTICS, INC. LOAN AGREEMENT, SECURITY AGREEMENT and 10% CONVERTIBLE,
SECURED PROMISSORY NOTE (the "First Amendment") is made and entered into as of
April 12, 2005, by and among NORTHWEST BIOTHERAPEUTICS, INC., a Delaware
corporation (the "Maker") and Toucan Capital fund II, L.P. (the "Holder"). This
First Amendment amends the Note (as defined below).

                                    RECITALS

A. Section 17.6 of that certain Amended and Restated Northwest Biotherapeutics,
Inc. Loan Agreement, Security Agreement and 10% Convertible, Secured Promissory
Note, dated as of July 30, 2004 and originally issued on April 26, 2004, by and
between the Maker and the Holder (the "Note"), states that no provision of such
note may be amended or waived without the express written consent of both Maker
and Holder; and

B. The Maker and the Holder wish to amend the Note as provided below.

                                    AGREEMENT

        NOW, THEREFORE, in consideration of these premises and for other good
and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties hereto agree as follows:

1. Section 1 of the Note is hereby amended to provide that the Maturity Date is
June 26, 2005 or such earlier date as may be applicable under Sections 3 and 4
thereof.

2. All other terms and conditions of the Note shall be unaffected hereby and
remain in full force and effect.

3. This First Amendment shall be governed by and construed under the laws of the
State of Delaware without giving effect to principles of conflicts of laws of
the State of Delaware or any other state.


                            [SIGNATURE PAGE FOLLOWS]


<PAGE>


        IN WITNESS WHEREOF, the parties hereto have executed this FIRST
AMENDMENT TO AMENDED AND RESTATED NORTHWEST BIOTHERAPEUTICS, INC. LOAN
AGREEMENT, SECURITY AGREEMENT AND 10% CONVERTIBLE, SECURED PROMISSORY NOTE as of
the date first above written.

MAKER:

NORTHWEST BIOTHERAPEUTICS, INC.,
a Delaware corporation

By:
    --------------------------------
Name:
      ------------------------------
Title:
       -----------------------------


HOLDER:

TOUCAN CAPITAL FUND II, L.P.

By:
    --------------------------------
Name:
      ------------------------------
Title:
       -----------------------------
**Exhibit 15.2**January 30, 2007Securities and Exchange Commission
I 

115TH CONGRESS 

2D SESSION H. R. 4799 

To require the Secretary of the Treasury to determine improvements in 

the filing process for the excise tax on the use of heavy highway motor 

vehicles. 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 16, 2018 

Mr. CRAMER introduced the following bill; which was referred to the 

Committee on Ways and Means 

A BILL 

To require the Secretary of the Treasury to determine improvements in the filing process for the excise tax on 

the use of heavy highway motor vehicles. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. STUDY TO IMPROVE ADMINISTRATION OF EX4 CISE TAX ON USE OF HEAVY HIGHWAY VEHI5 CLES. 

6 (a) IN GENERAL.—The Secretary of the Treasury (or 

7 the Secretary’s designee) shall conduct a study on improv8 ing the filing process for the tax imposed by section 4481 

9 of the Internal Revenue Code of 1986 (including the adVerDate Sep 11 2014 00:44 Jan 18, 2018 Jkt 079200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H4799.IH H4799

rfrederick on DSKBCBPHB2PROD with BILLS
2 

•HR 4799 IH

1 ministration of any exceptions to the application, or sus2 pension of collection, of such tax). 

3 (b) SUBMISSION OF REPORT.—Not later than 180 

4 days after the date of the enactment of this Act, the Sec5 retary (or such designee) shall submit to the Committee 

6 on Ways and Means of the House of Representatives and 

7 the Committee on Finance of the Senate a report which— 

8 (1) details the results of such study; and 

9 (2) includes a description of any changes the 

10 Secretary could make, and any suggested changes to 

11 statutory law, to improve such process. 

Æ 


rfrederick on DSKBCBPHB2PROD with BILLS
#### In re Habeas Corpus of Donald Keith REA.

No. A-12117.

Criminal Court of Appeals of Oklahoma.

Sept. 8, 1954.

Elmore A. Page, Tulsa, for petitioner.

POWELL, Presiding Judge.

This, an original action in habeas corpus, was instituted by the petitioner, Donald Keith Rea, for the purpose of being discharged from incarceration in the county jail of Tulsa County, or in lieu thereof, that the bond fixed at $7,500 and which the petitioner has been unable to make, be reduced.

The petitioner alleges that he is being held by district court information for the offense of first degree rape. It is alleged that he was arrested on the charge on or about March 8, 1954; that a preliminary hearing was had in the court of common pleas of Tulsa County, and defendant was bound over to the district court without bond. An information was filed in the district court of Tulsa County wherein petitioner was charged with first degree rape. He caused to be filed a petition for writ of habeas corpus in that court, and bond was fixed by the court in the sum of $7,500.

Petitioner claims that he has been denied his constitutional right to a speedy trial in that a criminal jury docket was held during the latter part of April and the first part of May, 1954 and although defendant’s case was on the docket, he was not tried.

The county attorney of Tulsa County has failed to respond to the petition, as required by order of this court, and made no appearance when the petition came on for hearing on September 2, 1954.

We have examined the transcript of the preliminary hearing. The record made at hearing of the petition for writ of habeas corpus in the district court of Tulsa County is not before us.

The transcript presented reveals that Jean Thompson, thirteen years of age, and another girl were hitch hiking and went riding with the defendant and two other boys. There was evidence that she was raped. By reason of the fact that the case is scheduled for trial, we shall not detail the evidence. However, so far as the testimony at the preliminary is concerned, there was a sharp conflict. There is no dispute but that the petitioner did go riding with the prosecu-trix.

In view of the facts and circumstances in the record, we have reached the conclusion that under the law petitioner is entitled to bail in the reasonable sum of Five Thousand ($5,000) Dollars.

*1040It does not appear that a second term of court has expired since the filing of the information, and petitioner is not at this time entitled to a discharge on account of delay of trial.

It is therefore ordered that the petitioner is hereby admitted to bail in the sum of Five Thousand ($5,000) Dollars for appearance for trial before the district court of Tulsa County, said bond to be conditioned as provided by law, and approved by the Court Clerk of Tulsa County.

JONES and BRETT, JJ., concur.
_____________________________________ 

Page is not included in this copy. 

Pages 9 through 13 are not included in this copy. 

_______________________________________________________________ 

The material not included contains the following type of 

information: 

_____ Identity of product inert ingredients. 

_____ Identity of product impurities. 

_____ Description of the product manufacturing process. 

_____ Description of quality control procedures. 

_____ Identity of the source of product ingredients. 

_____ Sales or other commercial/financial information. 

_____ A draft product label. 

_____ The product confidential statement of formula. 

_____ Information about a pending registration action. 

__X___ FIFRA registration data. 

____ The document is a duplicate of page(s) ____. 

_____ The document is not responsive to the request. 

_____ Proprietary information pertaining to the chemical 

 composition of an inert ingredient provided by the source 

 of the ingredient. 

_____ Attorney-Client Privilege. 

____ Claimed Confidential by submitter upon submission to the 

 Agency. 

_____ Internal Deliberative Information. 

 

 

* The information not included is generally considered confidential by product 

registrants. If you have any questions, please contact the individual who 

prepared the response to your request. 

_________________________________________________________________
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5109 Introduced in House (IH)]

<DOC>

115th CONGRESS
  2d Session
                                H. R. 5109

      To amend the 21st Century Cures Act to ensure the equitable 
distribution of resources to address the opioid epidemic, and for other 
                               purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           February 27, 2018

Ms. Kuster of New Hampshire (for herself, Mr. Jenkins of West Virginia, 
  Mr. McKinley, Ms. Blunt Rochester, Mr. Poliquin, and Mr. Courtney) 
 introduced the following bill; which was referred to the Committee on 
                          Energy and Commerce

_______________________________________________________________________

                                 A BILL

 
      To amend the 21st Century Cures Act to ensure the equitable 
distribution of resources to address the opioid epidemic, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Federal Opioid Response Fairness Act 
of 2018''.

SEC. 2. EQUITABLE DISTRIBUTION OF RESOURCES TO ADDRESS THE OPIOID 
              EPIDEMIC.

    (a) In General.--The second sentence in paragraph (1) of section 
1003(c) of the 21st Century Cures Act (Public Law 114-255; 42 U.S.C. 
290ee-3 note) is amended by striking ``States with an incidence or 
prevalence of opioid use disorders that is substantially higher 
relative to other States.'' and inserting ``States--''
                    ``(A) with a prevalence of opioid use disorders and 
                associated adverse health effects, including neonatal 
                abstinence syndrome, that is substantially higher 
                relative to other States; and
                    ``(B) with a per capita prescription opioid, 
                heroin, or synthetic opioid overdose mortality rate 
                that is substantially higher relative to other 
                States.''.
    (b) Minimum Amount of Grants.--Section 1003(c) of the 21st Century 
Cures Act (Public Law 114-255; 42 U.S.C. 290ee-3 note) is amended by 
adding at the end the following new paragraph:
            ``(3) Minimum amount of grants.--Subject to the 
        availability of appropriations, the amount of a grant awarded 
        under this subsection shall not be less than $5,000,000.''.
    (c) Technical Amendment.--The first sentence in paragraph (1) of 
section 1003(c) of the 21st Century Cures Act (Public Law 114-255; 42 
U.S.C. 290ee-3 note) is amended by striking ``in accordance with 
subparagraph (B)'' and inserting ``in accordance with paragraph (2)''.
    (d) Effective Date.--The amendments made by subsections (a) and (b) 
shall take effect on October 1, 2018.
                                 <all>
```